| 000 | 00902 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513085337.0 | ||
| 264 | 0 | _c19960322 | |
| 008 | 199603s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/00007691-199512000-00012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNorman, D J | |
| 245 | 0 | 0 |
_aMechanisms of action and overview of OKT3. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cDec 1995 |
||
| 300 |
_a615-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMuromonab-CD3 _xpharmacology |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 17 _gno. 6 _gp. 615-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007691-199512000-00012 _zAvailable from publisher's website |
| 999 |
_c8587281 _d8587281 |
||